Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Exenatide IR (immediate-release) is given twice daily, while exenatide ER is a once-weekly microsphere formulation
Summary: Retatrutide is an unlicensed investigational triple agonist associated with dose-dependent increases in resting heart rate, though dedicated cardiovascular outcomes trial data are not yet available
Many patients expect dramatic changes during the first week, but healthy weight management is usually a gradual process
It is not recommended in pregnancy or breastfeeding, is not established in those under 18, and is generally not recommended at 75 years or older
US$ 23.19
US$ 24.28
US$ 24.79
